Clinical Trial

Effect of Systemic and Local Ozone Therapy in Lipedema

Completed
View on ClinicalTrials.gov →
Summary
Lipedema is a disease characterized by enlargement of the subcutaneous tissue and is observed only in the female population. Recently, the inflammatory cascade has been suggested to be the initiator of lipoedema and to play a role in its progression. The presence of pain in the involved areas is the most important symptom affecting the patient's QoL. In the literature, ozone therapy is used both locally and systemically in many diseases in which inflammation is involved in the etiopathogenesis. There are many studies on plantar fasciitis, lateral epicondylitis, rheumatoid arthritis, osteoarthritis, etc. In addition to its anti-inflammatory properties, ozone therapy, which has analgesic and aseptic properties, has not been found in the literature in patients with lipedema. The aim of this study was to investigate the effect of ozone therapy on pain symptoms and subcutaneous tissue thickness in patients with lipedema and to compare local and systemic ozone applications in these patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-30; most recent amendment 2026-03-30.
Status change: Recruiting → Completed 2026-03-30
Status change: Active, Not Recruiting → Recruiting 2025-07-15
Trial Details
NCT Number NCT06954870
Lead Sponsor Ankara Etlik City Hospital
Conditions Lipedema, Pain, Activities of Daily Living, Musculoskeletal Ultrasound
Enrollment 45 participants
Start Date 2025-03-25
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-31